Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period

1.5 / 5 stars · 27/93 Roast Me

VYOME HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period

VYOME HOLDINGS, INC. (HIND) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 227.00 thousand shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-22.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2019-02-22

  • VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2018-12-31 was 15.00K shares.
  • VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2018-09-30 was 76.00K shares.
  • VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2018-06-30 was 86.00K shares.
  • VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2018-03-31 was 50.00K shares.
  • VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2018 was 227.00K shares.
  • VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2017 was 0.00 shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month
2018-12-3115.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
91.00K shares
derived: sum of 2 quarters · filed 2019-02-22
177.00K shares
derived: sum of 3 quarters · filed 2019-02-22
227.00K shares
10-K · filed 2019-02-22
2018-09-3076.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
162.00K shares
derived: sum of 2 quarters · filed 2018-11-02
212.00K shares
10-Q · filed 2018-11-02
212.00K shares
derived: sum of 4 quarters · filed 2018-11-02
2018-06-3086.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
136.00K shares
10-Q · filed 2018-08-02
136.00K shares
derived: sum of 3 quarters · filed 2018-08-02
2018-03-3150.00K shares
10-Q · filed 2018-05-10
50.00K shares
derived: sum of 2 quarters · filed 2018-05-10
2017-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
0.00 shares
10-K · filed 2018-03-05
2017-09-300.00 shares
10-Q · filed 2017-11-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36